HomeEWTX • NASDAQ
add
Edgewise Therapeutics Inc
Previous close
$14.45
Day range
$14.26 - $14.99
Year range
$10.60 - $38.12
Market cap
1.55B USD
Avg Volume
1.77M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 45.96M | 32.24% |
Net income | -40.80M | -43.03% |
Net profit margin | — | — |
Earnings per share | -0.43 | -30.30% |
EBITDA | -45.45M | -32.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 436.39M | -18.09% |
Total assets | 454.39M | -17.95% |
Total liabilities | 24.67M | 30.78% |
Total equity | 429.72M | — |
Shares outstanding | 105.20M | — |
Price to book | 3.20 | — |
Return on assets | -24.41% | — |
Return on capital | -25.58% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -40.80M | -43.03% |
Cash from operations | -37.87M | -32.41% |
Cash from investing | 43.90M | 116.36% |
Cash from financing | 2.22M | -99.08% |
Net change in cash | 8.26M | 114.79% |
Free cash flow | -23.38M | -23.98% |
About
Founded
2017
Headquarters
Website
Employees
117
